These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 25171296

  • 1. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction.
    Flores-Monroy J, Ferrario CM, Valencia-Hernández I, Hernández-Campos ME, Martínez-Aguilar L.
    Pharmacology; 2014; 94(1-2):21-8. PubMed ID: 25171296
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive Properties of a Novel Morphologic Derivative (4-tert-buthyl-2,6-bis(thiomorpholine-4-ilmethyl)phenol).
    Martínez-Aguilar L, Lezama-Martínez D, Orozco-Cortés NV, González-Espinosa C, Flores-Monroy J, Valencia-Hernández I.
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):246-51. PubMed ID: 26566152
    [Abstract] [Full Text] [Related]

  • 3. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 4. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P, Lavandero S.
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [Abstract] [Full Text] [Related]

  • 5. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM.
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
    Sharp S, Poglitsch M, Zilla P, Davies NH, Sturrock ED.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657
    [Abstract] [Full Text] [Related]

  • 7. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH, Moltzer E, van Veghel R, Garrelds IM, Leijten F, Bouhuizen AM, Danser AH.
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [Abstract] [Full Text] [Related]

  • 8. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
    Xiao HL, Li CS, Zhao LX, Yang J, Tong N, An L, Liu QT.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
    [Abstract] [Full Text] [Related]

  • 9. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, Hyakkoku M, Taniguchi S, Shimamoto K.
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [Abstract] [Full Text] [Related]

  • 10. Role of angiotensin in the dipsogenic effect of bradykinin in rats.
    Rowland NE, Fregly MJ.
    Pharmacol Biochem Behav; 1997 Aug; 57(4):699-705. PubMed ID: 9258997
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM.
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats.
    de Resende MM, Kauser K, Mill JG.
    Life Sci; 2006 May 22; 78(26):3066-73. PubMed ID: 16413583
    [Abstract] [Full Text] [Related]

  • 13. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
    Tokita Y, Oda H, Franco-Saenz R, Mulrow PJ.
    Proc Soc Exp Biol Med; 1995 Apr 22; 208(4):391-6. PubMed ID: 7700888
    [Abstract] [Full Text] [Related]

  • 14. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 22; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
    Lapointe N, Blais C, Adam A, Parker T, Sirois MG, Gosselin H, Clément R, Rouleau JL.
    J Am Coll Cardiol; 2002 May 15; 39(10):1692-8. PubMed ID: 12020499
    [Abstract] [Full Text] [Related]

  • 16. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
    Mill JG, Milanez Mda C, Busatto VC, de Moraes AC, Gomes Mda G.
    Arq Bras Cardiol; 1997 Aug 15; 69(2):101-10. PubMed ID: 9567332
    [Abstract] [Full Text] [Related]

  • 17. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JM, de Bruijn RJ, de Vries R, Danser AH.
    Hypertension; 2005 Jan 15; 45(1):120-5. PubMed ID: 15583077
    [Abstract] [Full Text] [Related]

  • 18. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY, Chen DG, Chen SC, Jin XQ, Wang HJ.
    Zhongguo Yao Li Xue Bao; 1996 Nov 15; 17(6):507-12. PubMed ID: 9863143
    [Abstract] [Full Text] [Related]

  • 19. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B, de Vries R, Saxena PR, Danser AH.
    Hypertension; 2001 Jul 15; 38(1):95-9. PubMed ID: 11463767
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM, Burrell LM, Kladis A, Campbell DJ.
    J Card Fail; 1997 Mar 15; 3(1):41-52. PubMed ID: 9110254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.